NAD Supplements in 2025: NMN vs NR vs Liposomal vs Injectable
NAD+ declines by roughly 50% between your 20s and 50s — that decline is real, and it matters for cellular energy and repair.
Both NMN and NR reliably raise blood NAD+ in humans. The dramatic longevity claims mostly still live in mouse studies.
NR has a slight edge in independent human clinical data; NMN has more momentum and recent muscle and metabolic trial results.
Liposomal and injectable forms offer higher bioavailability, but better absorption doesn't automatically mean better outcomes.
The cancer metabolism concern is real enough to warrant a conversation with your clinician if you have risk factors — don't skip that step.
A supplement without your baseline labs is just a guess. Start with your data.
Clinical supervision is what separates a structured protocol from an expensive experiment on yourself.
The NAD Supplement Market Is a Mess. Let's Clean It Up.
Walk into any supplement store — or, more likely, scroll through any wellness corner of the internet — and you'll find at least a dozen products all promising to "boost your NAD+" for energy, longevity, and brain function. NMN capsules, NR powder, liposomal formulas, sublingual drops, and now injectable NAD+. Everyone's selling something, and everyone's got a "study" to back it up.
Here's the honest version: NAD+ is a genuinely important molecule, the research behind it is real, and some of the products out there are worth your attention. But the supplement industry has gotten way ahead of the human clinical data, and a lot of what you're reading is extrapolated from mouse studies or funded by the companies selling you the pills.
This guide breaks down what NAD+ actually does, what each delivery form does to your body, what the 2025 evidence actually supports, and how to figure out whether any of this is worth your money and effort.
What Is NAD+, Really?
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every living cell. It's central to two things your body cares deeply about: making energy and repairing damage. Think of it as the molecule that keeps the lights on and fixes the wiring at the same time.
It was first identified by chemists Arthur Harden and William John Young back in 1906, while studying fermentation in yeast. For most of the 20th century, it was studied mostly in the context of metabolism. Then, in the early 2000s, researchers started connecting it to sirtuins (a family of proteins linked to aging and stress response) and PARP enzymes (which repair broken DNA). Suddenly, NAD+ wasn't just a metabolism molecule — it was a potential longevity target.
Here's the catch: your NAD+ levels decline with age. By the time you're in your 50s, your NAD+ levels may be roughly 50% lower than they were in your 20s, based on tissue measurements in rodent studies and some early human data. That decline has been associated with mitochondrial dysfunction, slower DNA repair, and increased inflammation — all hallmarks of biological aging.
The obvious question: can you just take NAD+ and reverse that? Not quite. NAD+ itself is a large, charged molecule that doesn't survive oral digestion well. So the supplement industry went upstream, to the precursors your cells use to make NAD+ internally.
How NAD+ Is Made: The Precursor Ladder
Your body makes NAD+ from several starting materials. The most important ones for supplement purposes are:
- Tryptophan: the amino acid found in food, converted through a long pathway. Slow and inefficient.
- Nicotinic acid (niacin, or NA): the original form, cheap, effective, but causes flushing in most people at useful doses.
- Nicotinamide (NAM): the amide form of niacin, no flush, but it actually inhibits sirtuins at high doses — which somewhat defeats the purpose.
- Nicotinamide riboside (NR): a more recently identified precursor, discovered to efficiently raise NAD+ in humans. Enters the cell and converts via NMN.
- Nicotinamide mononucleotide (NMN): one step closer to NAD+ than NR. Became famous largely because David Sinclair, the Harvard longevity researcher, wrote about taking it daily.
Both NR and NMN raise blood NAD+ in humans. That much is established. What's far less clear is whether that translates into meaningful health outcomes in otherwise-healthy adults.
NMN vs NR: What Does the 2025 Evidence Actually Show?
Ready for some science that won't put you to sleep? Let's do this quickly.
NMN (Nicotinamide Mononucleotide)
NMN has the most hype behind it, partly because of Sinclair's public advocacy and partly because the mouse data is impressive. In rodent studies, NMN supplementation has improved muscle function, reversed vascular aging, and extended healthy lifespan. You are not a mouse. But the mouse data is at least pointing in an interesting direction.
Human trials are catching up. A 2022 randomized controlled trial in healthy middle-aged adults found that 250 mg/day of NMN for 12 weeks significantly increased blood NAD+ levels and improved muscle insulin sensitivity in older women. A 2023 trial showed improvements in gait speed and grip strength in older adults taking 250–500 mg/day. These are modest but real signals.
One important nuance: NMN doesn't actually cross cell membranes directly in its original form. It gets dephosphorylated to NR first, absorbed, then rebuilt inside cells. So the "NMN is one step closer to NAD+" argument is a bit oversimplified.
NR (Nicotinamide Riboside)
NR has slightly more human trial data than NMN, partly because it's been commercially available longer and has been studied by independent labs (not just supplement-funded ones). Multiple trials have confirmed that oral NR at doses of 300–1000 mg/day reliably raises whole-blood NAD+ by 40–90%. That's not trivial.
Where the evidence gets murkier is in the downstream effects. A well-designed 2020 trial in healthy older adults found that NR raised NAD+ significantly but didn't improve cardiovascular function, skeletal muscle, or mitochondrial biogenesis beyond what was seen in placebo groups. A 2023 trial in people with mild cognitive impairment showed some promising signals in brain NAD+ levels and cognitive biomarkers, but was underpowered.
Bottom line on NMN vs NR: they both work at raising NAD+. The clinical benefit evidence is preliminary for both, with NR having a slight edge in independent human data. Neither has a definitive outcome trial in healthy aging adults.
What About Liposomal NAD+ Supplements?
Liposomal delivery wraps the active ingredient in a lipid (fat) layer that's meant to survive digestion and get absorbed more efficiently through the gut wall. It's the same technology used in some pharmaceutical formulations and, more recently, in supplements like liposomal vitamin C.
For NAD+ precursors, the liposomal approach is supposed to improve bioavailability — meaning more of what you swallow actually gets into circulation. There are some small pharmacokinetic studies suggesting liposomal NR or NMN may reach higher peak plasma levels than standard capsules. But we don't yet have head-to-head trials comparing liposomal versus standard forms on actual health outcomes.
The honest take: liposomal formulations probably aren't a scam, but the premium pricing often isn't justified by the available evidence. You're paying for better absorption, but "better absorbed into blood" doesn't automatically mean "better outcomes in your cells." The science of intracellular delivery is still catching up to the marketing.
Injectable NAD+: The Highest Bioavailability Option
Injectable NAD+ (administered intravenously or subcutaneously) bypasses the digestive system entirely, delivering NAD+ directly into circulation. This is the only delivery method that avoids the first-pass metabolism problem altogether.
IV NAD+ infusions have been used clinically, mostly in addiction medicine and some neurological applications, for decades. The anecdotal reports from people who've done IV NAD+ — rapid cognitive clarity, mood improvement, energy surge — are compelling enough that it's become popular in longevity clinics. But the clinical evidence base for IV NAD+ in otherwise-healthy aging adults is thin. Most of the published data involves people recovering from addiction or with specific metabolic conditions.
Subcutaneous NAD+ injections (self-administered, like insulin) are a newer format that's more accessible than IV infusions and sidesteps many of the digestive bioavailability issues. This is what serious longevity protocols are starting to explore.
The trade-off: injectable forms cost significantly more than oral supplements, require some administration skill, and the evidence that they do more than oral precursors for healthy aging isn't yet established. They're the most bioavailable option, but bioavailability alone isn't the whole story.
NAD+ Supplement Benefits: What the Evidence Actually Supports
Here's where we separate signal from noise. These are the areas where the human evidence is most credible, along with honest caveats:
- Raising blood NAD+ levels: This one's not disputed. Both NR and NMN reliably raise circulating NAD+ in humans. Whether blood NAD+ reflects what's happening in tissues like muscle, brain, and liver is a separate question — and the answer is: we're not entirely sure.
- Muscle function and insulin sensitivity: The 2022 NMN trial showing improvements in muscle insulin sensitivity in older women is one of the cleaner human signals. A few NR trials have shown modest improvements in muscle endurance markers. Promising, but not yet definitive.
- Cardiovascular function: Preclinical data is strong. Human evidence is weaker. A 2022 trial showed NR improved aortic stiffness in middle-aged and older adults at 1000 mg/day, which is a meaningful cardiovascular outcome. But it's a single trial.
- Brain health and cognitive aging: NAD+ is essential for neuronal energy metabolism and DNA repair in neurons. The 2023 cognitive impairment trial with NR showed some biomarker improvements. Long COVID-related cognitive dysfunction is an active area of NR research with some early positive signals.
- DNA repair capacity: NAD+ fuels PARP enzymes, which repair broken DNA strands. In theory, higher NAD+ should mean better DNA repair. Direct evidence in humans is mostly biomarker-level, not outcome-level.
The Reality Check
The internet wants NAD+ to be a fountain of youth in a capsule. The research is more interesting — and more humble — than that.
Most of the dramatic longevity findings come from mouse studies. Mice are great models for mechanisms but terrible predictors of human outcomes, particularly for complex processes like aging. We've "cured" aging in mice with dozens of interventions that didn't pan out in people.
The human trials we have are mostly short (12–16 weeks), small (20–100 participants), and often industry-funded. The outcome measures — blood NAD+ levels, insulin sensitivity, walking speed — are proxies, not lifespan data. We simply don't have a 10-year randomized trial telling us that NR or NMN extends healthy lifespan in humans.
None of this means it's not worth considering. It means you should calibrate your expectations. NAD+ precursors are probably the most credible longevity supplement category in 2025. "Probably credible" is meaningfully different from "proven."
Who Is This Actually Right For?
NAD+ precursor supplementation makes the most sense if you fit one or more of these profiles:
- Adults over 40 who are interested in proactive cellular health support, particularly around mitochondrial function and metabolic resilience.
- Active people noticing slower recovery or energy dips that feel age-related rather than lifestyle-related.
- People with metabolic concerns — insulin resistance, pre-diabetes, elevated fasting glucose — where the muscle insulin sensitivity data is most relevant.
- People with cognitive concerns or brain fog, including those dealing with post-viral fatigue or long COVID, where the early NR brain data is most applicable.
- Anyone already doing a structured longevity protocol who wants to add NAD+ support as a complement to other interventions.
If you're under 35, healthy, and your labs are clean, the marginal benefit is speculative. That's not a reason to avoid it, but it's a reason to keep your expectations proportional.
Risks and Side Effects
NAD+ precursors are generally well-tolerated. But there are a few things worth knowing:
- Nausea and GI discomfort: the most common complaint, especially at higher doses. Usually resolves when taken with food.
- Flushing: not a concern with NMN or NR (it's a niacin thing), but worth knowing if you're ever looking at niacin-based products.
- Sleep disruption: some people report vivid dreams or lighter sleep when taking NMN/NR in the evening. Morning dosing is usually recommended.
- Cancer considerations: there's theoretical concern that NAD+ — which fuels cellular energy metabolism — could also fuel cancer cell growth. This is a legitimate mechanistic concern, not just speculation. People with active cancer or a high cancer risk profile should discuss this with their doctor before supplementing.
- Drug interactions: currently minimal known interactions, but NAD+ metabolism intersects with methylation pathways. If you're on medications that affect methylation (certain psychiatric drugs, for example), it's worth flagging to your clinician.
How to Get Started With NAD+ Support Through Healthspan
If you've read this far and you're thinking "okay, this is probably worth trying" — the next question is which form, which dose, and whether you actually need it based on your current biology.
That's exactly where Healthspan's Longevity Optimization program comes in. Rather than guessing at a dose based on what a podcast host recommends, you start with labs that tell you something about your actual metabolic state — including biomarkers relevant to mitochondrial health and cellular aging. A clinician reviews your results, discusses your health history, and builds a protocol that might include NAD+ precursor support alongside other evidence-based interventions.
For those who want a cleaner entry point, the Longevity Pro Panel gives you a comprehensive baseline — the kind of data that tells you whether your cellular health metrics suggest you'd be a strong responder to NAD+ supplementation or whether something else should come first.
If mitochondrial health is your specific focus, the Mitophagy Formula is designed to support the whole mitochondrial renewal process, not just NAD+ levels in isolation. It stacks well with NAD+ precursors in a structured protocol. The Cellular Renewal Stack takes a similarly integrated approach, combining multiple pathways relevant to cellular aging.
The difference between a supervised Healthspan protocol and buying a bottle off Amazon isn't just the formulation — it's the clinical context. You get someone who actually looks at your numbers, adjusts your protocol over time, and catches things that a supplement label never will. If you're going to take this seriously, start with your data, not a shopping cart.
Frequently Asked Questions About NAD Supplements
What is the best NAD supplement for anti-aging?
There's no single "best" NAD supplement — it depends on your goals, budget, and what form your body absorbs most efficiently. NR has more independent human clinical data; NMN is more popular but most of its dramatic results are in animal studies. Both reliably raise blood NAD+ levels. For aging-related goals, dose matters too: most human trials showing measurable effects use 250–1000 mg daily.
Is NMN or NR better for raising NAD+ levels?
Both NMN and NR raise whole-blood NAD+ in humans, and direct comparison trials don't show a dramatic difference. NR has a longer track record of independent human studies. NMN has more preclinical data and recent human trials showing muscle and metabolic benefits. Either can work — the quality of the formulation and the dose matter more than the specific precursor choice for most people.
How long does it take for NAD supplements to work?
Blood NAD+ levels typically rise within 1–2 weeks of consistent supplementation with NR or NMN. Subjective effects like energy or cognitive clarity are reported by some users within days, though these are hard to separate from placebo effect. For measurable physiological outcomes — like improvements in insulin sensitivity or muscle function — clinical trials typically show changes over 8–16 weeks of daily supplementation.
Are NAD supplements safe to take long-term?
NR and NMN have a reasonable short-term safety profile in human trials, with mostly mild GI side effects. Long-term safety data beyond 12–16 weeks is limited, since most trials are short. There is a theoretical concern about NAD+ fueling cancer cell metabolism, so people with active cancer or very high cancer risk should consult a physician before starting. For most healthy adults, current evidence doesn't raise major red flags for long-term use.
Do NAD supplements actually work, or is it just hype?
They work at what they're measurably supposed to do: raise blood NAD+ levels. Whether that translates into meaningful anti-aging or longevity outcomes in healthy humans is still being established. The mouse data is compelling. The early human data shows some promising signals in muscle function, cardiovascular markers, and cognitive health. The honest answer is: probably useful, not yet proven, and more credible than most longevity supplements.
What's the difference between liposomal NAD+ and regular NMN or NR supplements?
Liposomal formulations wrap the active ingredient in a fat layer to improve absorption through the gut. They likely deliver higher peak blood concentrations than standard capsules. Whether this translates into better outcomes isn't yet proven in head-to-head trials. You're paying for better theoretical bioavailability, but the premium pricing isn't always justified by evidence of meaningfully different health results compared to standard oral NR or NMN at equivalent doses.
Can I get injectable NAD+ through a longevity clinic?
Yes. Injectable NAD+ (both IV infusions and subcutaneous injections) bypasses digestion entirely, giving the highest bioavailability of any delivery method. Clinically supervised longevity programs can include injectable NAD+ as part of a structured protocol, alongside labs and ongoing monitoring. This is the most expensive and highest-bioavailability option, though human outcome data comparing injectable to high-dose oral forms in healthy adults is still limited.
- Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224–1229. https://doi.org/10.1126/science.abe9985
- Conze D, Brenner C, Kruger CL. Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults. Sci Rep. 2019;9(1):9772. https://doi.org/10.1038/s41598-019-46120-z
- Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9(1):1286. https://doi.org/10.1038/s41467-018-03421-7
- Pencina KM, Lavu S, Apovian C, et al. 12-week supplementation with NMN improves muscle function and metabolism in older adults. J Clin Endocrinol Metab. 2023;108(8):1968–1980. https://doi.org/10.1210/clinem/dgad027
- Elhassan YS, Kluckova K, Fletcher RS, et al. Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures. Cell Rep. 2019;28(7):1717–1728. https://doi.org/10.1016/j.celrep.2019.07.043
- Dolopikou CF, Kourtzidis IA, Margaritelis NV, et al. Acute nicotinamide riboside supplementation improves redox homeostasis and exercise performance in old individuals: a double-blind cross-over study. Eur J Nutr. 2020;59(2):505–515. https://doi.org/10.1007/s00394-019-01919-4
- Liao B, Zhao Y, Wang D, et al. Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study. J Int Soc Sports Nutr. 2021;18(1):54. https://doi.org/10.1186/s12970-021-00442-4
- Airhart SE, Shireman LM, Risler LJ, et al. An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers. PLoS One. 2017;12(12):e0186459. https://doi.org/10.1371/journal.pone.0186459
- Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021;22(2):119–141. https://doi.org/10.1038/s41580-020-00313-x
- Katsyuba E, Romani M, Hofer D, Auwerx J. NAD+ homeostasis in health and disease. Nat Metab. 2020;2(1):9–31. https://doi.org/10.1038/s42255-019-0161-5